Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2011
Inhibition of the Notch-Hey1 axis blocks embryonal rhabdomyosarcoma tumorigenesisBrian C Belyea, Sarasija Naini, Rex C Bentley, et al.
Sarcoma|May 24, 2012
Embryonic signaling pathways and rhabdomyosarcoma: contributions to cancer development and opportunities for therapeutic targetingBrian Belyea, Julie Grondin Kephart, Jordan Blum, et al.
Frontiers in Oncology|September 22, 2015
A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue SarcomasMichael D Deel, Jenny J Li, Lisa E S Crose, et al.
Cancer Research|June 3, 2005
Genetic modeling of human rhabdomyosarcomaCorinne M Linardic, Diane L Downie, Stephen Qualman, et al.
Cancer Research|December 18, 2003
Differential effects of rapamycin on mammalian target of rapamycin signaling functions in mammalian cellsAimee L Edinger, Corinne M Linardic, Gary G Chiang, et al.
Molecular Cancer Therapeutics|June 19, 2003
Characterization of the cytotoxic activities of novel analogues of the antitumor agent, lavendamycinYanan Fang, Corinne M Linardic, D Ashley Richardson, et al.
Plos One|October 27, 2015
Role of the YAP Oncoprotein in Priming Ras-Driven RhabdomyosarcomaKatherine K Slemmons, Lisa E S Crose, Erin Rudzinski, et al.
Cancer Research|July 20, 2007
The PAX3-FKHR fusion gene of rhabdomyosarcoma cooperates with loss of p16INK4A to promote bypass of cellular senescenceCorinne M Linardic, Sarasija Naini, James E Herndon, et al.
Molecular Cancer Research : MCR|September 20, 2017
A Novel Notch-YAP Circuit Drives Stemness and Tumorigenesis in Embryonal RhabdomyosarcomaKatherine K Slemmons, Lisa E S Crose, Stefan Riedel, et al.
Pharmacology & Therapeutics|October 2, 2025
Towards directed therapy for fusion-positive rhabdomyosarcomaGeorge M Turco, Sapna Oberoi, Brian Ladle, et al.
Pageof 6